04 Nov 2016

Report Of Meeting With MHRA On Regulation of Cannabidiol (CBD).

Yesterday, 3rd November 2016, six delegates from the UK Cannabis Trade Association (UKCTA) met with Medicines and Health Products Regulatory Agency (MHRA) representatives at the agency's headquarters in Victoria. We were courteously received. The meeting was cordial, productive and enabled both sides to clarify their positions and better understand each other's perspective. In...

01 Nov 2016

MHRA Backtracking Super Fast On CBD Ban.

In advance of the meeting between the UK Cannabis Trade Association (UKCTA) and the MHRA on Thursday, there has been a flurry of activity which amounts to a climb down by the regulator. This statement was published on the MHRA website at lunchtime today. "Update 1 November 2016 An MHRA spokesperson said: While MHRA has given its opinion that products containing cannabidiol (CBD) used for medical purposes are medicines, we have also carefully considered the needs of individuals using CBD products to treat or manage the...

30 Oct 2016

UK Cannabis Trade Association Meeting With MHRA This Week.

After all the speculation, many misleading and false reports and a plethora of attempts to interpret the MHRA's actions concerning cannabidiol (CBD), this week the chips are down. On Thursday 3rd November, at MHRA headquarters in Victoria, six representatives of the UK Cannabis Trade Association (UKCTA) will sit down with those responsible for the agency's statements on CBD. We will be armed with counsel's opinion on the legality of the MHRA's action but most importantly we...

19 Oct 2016

MHRA Confirms Meeting With CBD Industry Representatives.

Today, the Medicines and Healthcare products Regulatory Agency (MHRA), has arranged a meeting with representatives from the UK Cannabis Trade Association (UKCTA) to discuss its designation of cannabidiol (CBD) as a medicine. A request for a meeting was was first made in writing on 20th September 2016, when the possibility of the MHRA's action was still little more than a rumour.  Nearly six weeks later, after repeated requests, complaints and lobbying from many companies, individuals and MPs, the meeting has been fixed for 3rd November...

12 Oct 2016

The Man From The MHRA. Endangering Public Health With Precipitate Action On CBD.

The Medicines and Healthcare Products Regulatory Agency (MHRA) apparent decision to designate cannabidiol (CBD) as a medicine is an unholy mess and has been handled about as badly as it is possible for a government agency to deal with a matter of public safety. The desk of Dr Ian Hudson, the Chief Executive, will shortly be groaning under the weight of correspondence from MPs asking him to explain exactly what is going on.  We know that...

07 Oct 2016

Professor Mike Barnes Speaks Out On the CBD Ban.

Professor Mike Barnes, neurologist, scientific and medical advisor to CLEAR Cannabis Law Reform, has issued the following statement. "It is encouraging that the MRHA is recognising that CBD has medicinal value but it is concerning that many people benefitting from CBD now will suffer in the short term as good quality manufacturers have to stop production pending MRHA approval"  A redacted copy of the letter now being sent to all CBD...

05 Oct 2016

Fast Developing News On CBD And Medicinal Cannabis.

We learned today that the Medicines and Healthcare products Regulatory Agency (MHRA) has started issuing letters to CBD suppliers advising them that CBD is being designated as a medicine and that sale of CBD products must stop within 28 days. This will be alarming news to many people.  However, it is a complex situation which has some positive aspects to it.  In the short term, if you are already using CBD products, you would be well advised to stock up as much as you...